About The Medical Condition Evaluation Studies, FDA Phase III
Find the definition of the medical term Evaluation Studies, FDA Phase III. Evaluation Studies, FDA Phase III defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase III
Evaluation Studies, FDA Phase III Medical Condition |
---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase III?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Religious Belief ‐ A set of beliefs concerning the nature, cause, and purpose of…
- Cardiac Ruptures ‐ Laceration or tearing of the walls of the heart, of the interatrial…
- Tyrosine Hydroxylase ‐ An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin,…
- Achondroplasia ‐ An autosomal dominant disorder that is the most frequent form…
- Ticks ‐ Blood-sucking acarid parasites of the order Ixodida comprising…
- Benign Hepatomas ‐ A benign epithelial tumor of…
- Deficiency, Vitamin B6 ‐ A nutritional condition produced by a deficiency of VITAMIN B…
- Hyposensitization Therapies ‐ Immunosuppression by the administration of increasing doses of…
- Psychological Models ‐ Theoretical representations that simulate psychological processes…
- Anhydrous Tolmetin Sodium ‐ A non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS,…